Expert Review of Neurotherapeutics

Papers
(The H4-Index of Expert Review of Neurotherapeutics is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease55
Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system54
Therapeutic advances in Dravet syndrome: a targeted literature review45
Manganese-induced neurodegenerative diseases and possible therapeutic approaches39
Diagnosing and managing post-stroke aphasia38
Clinical diagnosis and management of small fiber neuropathy: an update on best practice35
Update on diagnosis in disorders of consciousness35
The emerging role of psilocybin and MDMA in the treatment of mental illness32
Sex differences in schizophrenia relevant to clinical care32
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies31
Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy29
Nutrition-based interventions for mood disorders27
Focal cortical dysplasia: an update on diagnosis and treatment27
Role of environmental factors in multiple sclerosis26
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults25
Pain in cervical dystonia: mechanisms, assessment and treatment25
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome23
Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis23
Emerging therapies in Friedreich’s Ataxia22
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?22
Clinical development of valbenazine for tics associated with Tourette syndrome22
Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs21
Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review21
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease21
Robot Assisted Ankle Neuro-Rehabilitation: State of the art and Future Challenges21
0.52205085754395